Skip to main content

Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It?

  • Conference paper
Cardiac Arrhythmias 2001
  • 70 Accesses

Zusammenfassung

Atrial fibrillation (AF) is the most frequent arrhythmia. Its frequency is constantly increasing together with the life span of the general population, since the incidence of AF rises with age. This arrhythmia should not be underestimated, because it leads to a significant increase of mortality [1] and of clinical events with a high medical cost: heart failure and systemic thromboembolism. Hence the rising involvement of health structures in order to manage the arrhythmia and its complications, with the contribution of different medical operators.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Benjamin EJ, Wolf PA, D’Agostino RB et al (1998) Impact of atrial fibrillation on the risk of death. The Framingham heart study. Circulation 98:946–952

    Article  CAS  PubMed  Google Scholar 

  2. Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449–1457

    Article  Google Scholar 

  3. Ezekowitz MD, James KE, Nazarian SM et al (1995) Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation 92:2178–2182

    Article  CAS  PubMed  Google Scholar 

  4. Petersen P, Boisen G, Godtfredsen J et al (1989) Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1:175

    Article  CAS  PubMed  Google Scholar 

  5. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323:1505

    Article  Google Scholar 

  6. Stoke Prevention in Atrial Fibrillation Investigators (1991) Stroke Prevention in Atrial Fibrillation Study: Final results. Circulation 84:527

    Article  Google Scholar 

  7. Connolly SJ, Laupacis A, Gent M et al (1991) Canadian Atrial Fibrillation Anti-Coagulation (CAFA) Study. J Am Coll Cardiol 18:349

    Article  CAS  PubMed  Google Scholar 

  8. Ezekowitz MD, Bridgers SL, James KE et al (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation (SPINAF). N Engl J Med 327:1406–1412

    Article  CAS  PubMed  Google Scholar 

  9. EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in nonrheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342:1255

    Google Scholar 

  10. Scardi S, Mazzone C (1997) La profilassi anticoagulante: dai grandi trial alia pratica clinica. G Ital Cardiol 28:171–183

    Google Scholar 

  11. Levine MN, Roaskob G, Landefeld S et al (1998) Haemorrhagic complications of anticoagulant treatment. Chest 114:511–523

    Article  Google Scholar 

  12. Landefeld CS, Beyth RJ (1993) Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention. Am J Med 95:315–328

    Article  CAS  PubMed  Google Scholar 

  13. Palareti G, Leali N, Coccheri S et al (1997) Complicanze emorragiche della terapia anticoagulante orale: risultati dello studio prospettico multicentrico ISCOAT. G Ital Cardiol 27:231–243

    CAS  PubMed  Google Scholar 

  14. Cortellazzo S, Finazzi G, Viero P et al (1993) Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemostasis 69:316–320

    Google Scholar 

  15. Bussey HL, Chiquette E, Amato M (1995) Anticoagulation clinic care versus routine medical care: a review and interim report. J Thomb Thrombolysis 2:315–319

    Article  Google Scholar 

  16. Ansell JE (1998) Anticoagulation management as a risk factor for adverse events: grounds for improvement. J Thromb Thrombolysis 5[Suppl]:S13–S18

    Article  PubMed  Google Scholar 

  17. Rosendaal FR (1996) The Scylla and Charybdis of oral anticoagulant treatment. N Engl J Med 335:587–589

    Article  CAS  PubMed  Google Scholar 

  18. Saour JN, Sieck JO, Mamo LAR et al (1990) Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 322:428–432

    Article  CAS  PubMed  Google Scholar 

  19. Leaning KE, Ansell JE (1996) Advances in the monitoring of oral anticoagulation: point-of-care testing, patient self-monitoring, and patient self-management. J Thromb Thrombolysis 3:377–383

    Article  PubMed  Google Scholar 

  20. Kitchen S, Preston FE (1997) Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins. J Clin Pathol 50:951–956

    Article  CAS  PubMed  Google Scholar 

  21. Ansell JE (1999) Empowering patients to monitor and manage oral anticoagulation therapy. J Am Med Assoc 281:182–183

    Article  CAS  Google Scholar 

  22. Andrew M, Marzinotto V, Leakar M et al (1997) Home monitoring of pediatric patients. Scientific Symposium: self-management of oral anticoagulation, State of the art, Florence, pp 20–25

    Google Scholar 

  23. Hasenlam M, Knudsen L, Kimose HH et al (1997) Practicability of patient self testing of oral anticoagulation therapy by the international normalized ratio using a portable whole blood monitor. Thrombosis Res 85:77–82

    Article  Google Scholar 

  24. White RH, McCurday SA, Von Marensdorff H et al (1998) Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Ann Intern Med 111:730–737

    Article  Google Scholar 

  25. Ansell JE, Patel N, Ostrovsky D et al (1995) Long-term patient self-management of oral anti coagulation. Arch Intern Med 155:2185–2189

    Article  CAS  PubMed  Google Scholar 

  26. Kaatz SS, White RH, Hill J et al (1995) Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard. Arch Intern Med 155:1861–1867

    Article  CAS  PubMed  Google Scholar 

  27. Hasenkam JM, Kimose L, Gronnesby H et al (1997) Self-management of oral anticoagulant therapy after heart valve replacement. Eur J Cardio Thorac Surg 11:935–942

    Article  CAS  Google Scholar 

  28. Bernardo A (1992) Home prothrombin estimation. In: Butchart EG, Bodnar E(eds) Thrombosis, embolism and bleeding. ICR, London pp 325–330

    Google Scholar 

  29. Sawicki PT (1999) A structured teaching and self-management program for patients receiving oral anticoagulation. A randomized controlled trial. J Am Med Assoc 281 (2)

    Google Scholar 

  30. Cromheecke ME, Levi M, Colly LP et al (2000) Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet 356:97–102

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Italia

About this paper

Cite this paper

Cazzin, R., Serra, P., Lestuzzi, C. (2002). Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It?. In: Raviele, A. (eds) Cardiac Arrhythmias 2001. Springer, Milano. https://doi.org/10.1007/978-88-470-2103-7_67

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2103-7_67

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2165-5

  • Online ISBN: 978-88-470-2103-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics